Loading...

Heat Biologics, Inc.

HTBXAMEX
Healthcare
Biotechnology
$2.38
$0.010(0.42%)

Heat Biologics, Inc. (HTBX) Stock Overview

Explore Heat Biologics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.3/100

Key Financials

Market Cap61.1M
P/E Ratio-1.69
EPS (TTM)$-1.15
ROE-0.31%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.93

HTBX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Heat Biologics, Inc. (HTBX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.93.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.69 and a market capitalization of 61.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;